• P = Professional
  • B = Behavioral health
  • F = Facilities

Farmacia

P B F
1 nov, 2024
The Medicare Prescription Payment Plan is a new payment option in the prescription drug law that wor...
P F
22 oct, 2024
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P B F
1 oct, 2024
Large Group and Small Group Markets FormularyThe information below is effective as of 1 de octubre, 202...
P F
1 oct, 2024
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P F
1 sep, 2024
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P F
1 ago, 2024
Drug Ilumya (J3256) has been listed as not needing a Prior Authorization (PA) for Commercial members...
P F
1 jul, 2024
Drug Ilumya (J3256) has been listed as not needing a Prior Authorization (PA) for Commercial members...
P B F
1 jul, 2024
Net Results UpdateThis information is effective as of 1 de julio de 2024, and applies to all commercial em...
P
1 jun, 2024
Fluticasone HFA has been added to all BCBSRI commercial formularies as a preferred tier medication.&...
P F
1 de mayo de 2024
Fluticasone HFA has been added to all BCBSRI commercial formularies as a preferred tier medication.&...
P F
18 abr, 2024
Fluticasone HFA has been added to all BCBSRI commercial formularies as a preferred tier medication.&...
P B F
1 abr, 2024
Large Group and Small Group Markets FormularyThe information below is effective as of 1 de abril de 2024 ...
P F
1 mar, 2024
Please note Avastin (J9035) does require Prior Authorization to be reviewed by Prime for Medicare me...
P
15 feb, 2024
If you have a patient with Covid-19 who is in one of our Medicare Advantage plans and you prescribe ...
P F
1 mar, 2023
For NEHP members with a RI PCP, inquiries regarding medical drugs should be directed to the member’s...
P F
6 feb, 2023
For NEHP members with a RI PCP, inquiries regarding medical drugs should be directed to the member’s...
P B F
1 ene, 2023
The Inflation Reduction Act (IRA) will take effect on 1 de enero de 2023.The Act includes the following...
P
1 ene, 2023
As a reminder effective 1 de enero de 2023, BCBSRI will cover the infliximab biosimilar products, Avsol...
P F
1 ene, 2023
As part of our ongoing efforts to make high-quality and affordable healthcare available to our membe...
P F
1 ene, 2023
Biosimilars: Are They the Same Quality? Use this infographic from the FDA to talk with your patient...
P F
7 dic, 2022
The Inflation Reduction Act (IRA) will take effect on 1 de enero de 2023.The Act includes the following...
P F
1 dic, 2022
Effective 1 de enero de 2023, BCBSRI will cover the infliximab biosimilar products, Avsola and Inflectr...
P
1 nov, 2022
Effective 1 de enero de 2023, BCBSRI will cover the infliximab biosimilar products, Avsola and Inflectr...
P B F
1 oct, 2022
Large Group and Small Group Markets Formulary The information on the above linked page is effective...